{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:00:18Z","timestamp":1793228418341,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia & Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bneo.2026.100229","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:29:23Z","timestamp":1775125763000},"page":"100229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Microenvironmentally derived fatty acid\u2013binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3845-9611","authenticated-orcid":false,"given":"Haylee","family":"Duval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7109-4512","authenticated-orcid":false,"given":"Katherine","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8852-2254","authenticated-orcid":false,"given":"Heather","family":"Fairfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8450-012X","authenticated-orcid":false,"given":"Alexander P.","family":"Corr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-1412","authenticated-orcid":false,"given":"Ya-Wei","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Belknap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-8069","authenticated-orcid":false,"given":"Kehinde","family":"Abayomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4172-2154","authenticated-orcid":false,"given":"Allyson","family":"Schimelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-6275","authenticated-orcid":false,"given":"Brian","family":"Nestor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5781-3488","authenticated-orcid":false,"given":"Edward","family":"Jachimowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9915-1780","authenticated-orcid":false,"given":"Patrizia J.","family":"Stohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangnan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0746-0854","authenticated-orcid":false,"given":"Matthew D.","family":"Lynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter I.","family":"Croucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Ryzhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2884-6481","authenticated-orcid":false,"given":"Michaela R.","family":"Reagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bneo.2026.100229_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers13020217","article-title":"The role of tumor microenvironment in multiple myeloma development and progression","volume":"13","author":"Garc\u00eda-Ortiz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bneo.2026.100229_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101856","article-title":"Bone marrow adipocytes is a new player in supporting myeloma cells proliferation and survival in myeloma microenvironment","volume":"40","author":"Wei","year":"2024","journal-title":"Transl Oncol"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2026.100229_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF03165279","article-title":"New insights into role of microenvironment in multiple myeloma","volume":"76","author":"Tricot","year":"2002","journal-title":"Int J Hematol"},{"issue":"12","key":"10.1016\/j.bneo.2026.100229_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33091","article-title":"Pathways to therapy resistance: the sheltering effect of the bone marrow microenvironment to multiple myeloma cells","volume":"10","author":"Bhowmick","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41408-022-00782-7","article-title":"Extreme body mass index and survival in newly diagnosed multiple myeloma patients","volume":"13","author":"Shah","year":"2023","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.bneo.2026.100229_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/leu.2014.295","article-title":"Diet-induced obesity promotes a myeloma-like condition in vivo","volume":"29","author":"Lwin","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40164-022-00303-z","article-title":"Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma","volume":"11","author":"Oudaert","year":"2022","journal-title":"Experimental hematology & oncology"},{"key":"10.1016\/j.bneo.2026.100229_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1118691","article-title":"Obesity and myeloma: clinical and mechanistic contributions to disease progression","volume":"14","author":"Marques-Mourlet","year":"2023","journal-title":"Front Endocrinol"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2026.100229_bib11","article-title":"Soluble signals exchanged between bone marrow adipocytes and myeloma cells alter the expression of metabolic genes in adipocytes and increase pro-survival molecules in myeloma cells","volume":"144","author":"Fairfield","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","article-title":"Acetyl-CoA synthetase 2: a critical linkage in obesity-induced tumorigenesis in myeloma","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.bneo.2026.100229_bib13","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1007\/s10238-023-01174-2","article-title":"Lipid metabolic vulnerabilities of multiple myeloma","volume":"23","author":"Torcasio","year":"2023","journal-title":"Clin Exp Med"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib14","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/1878-0261.13794","article-title":"Inhibition of acyl-CoA synthetase long-chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction","volume":"19","author":"Murphy","year":"2025","journal-title":"Molecular Oncology"},{"issue":"12","key":"10.1016\/j.bneo.2026.100229_bib15","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1158\/2767-9764.CRC-23-0350","article-title":"Statin-induced mitochondrial priming sensitizes multiple myeloma cells to BCL2 and MCL-1 inhibitors","volume":"3","author":"Juarez","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"uppl 1","key":"10.1016\/j.bneo.2026.100229_bib16","article-title":"A high-fiber dietary intervention (NUTRIVENTION) in precursor plasma cell disorders improves biomarkers of disease and may delay progression to myeloma","volume":"144","author":"Shah","year":"2024","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bneo.2026.100229_bib17","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3390\/cancers16091774","article-title":"Effects on the physical functioning of two exercise interventions in patients with multiple myeloma: a pilot feasibility study","volume":"16","author":"Hillengass","year":"2024","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.bneo.2026.100229_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17703","article-title":"Importance of fatty acid binding proteins in cellular function and organismal metabolism","volume":"28","author":"Agellon","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"suppl 3","key":"10.1016\/j.bneo.2026.100229_bib20","first-page":"23","article-title":"Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases","volume":"8","author":"Furuhashi","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"issue":"11","key":"10.1016\/j.bneo.2026.100229_bib21","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.0000141735.13202.B6","article-title":"Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice","volume":"110","author":"Boord","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bneo.2026.100229_bib22","first-page":"2640","article-title":"Adipocyte\/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice","volume":"118","author":"Furuhashi","year":"2008","journal-title":"J Clin Invest"},{"issue":"5291","key":"10.1016\/j.bneo.2026.100229_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","article-title":"Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein","volume":"274","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bneo.2026.100229_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2004.12.008","article-title":"Adipocyte\/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes","volume":"1","author":"Maeda","year":"2005","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2337\/diabetes.49.6.904","article-title":"Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-\/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein","volume":"49","author":"Shaughnessy","year":"2000","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.bneo.2026.100229_bib26","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1210\/endo.141.9.7637","article-title":"Improved glucose and lipid metabolism in genetically obese mice lacking aP2","volume":"141","author":"Uysal","year":"2000","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib27","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1038\/s41467-018-04987-y","article-title":"FABP4 as a key determinant of metastatic potential of ovarian cancer","volume":"9","author":"Gharpure","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.bneo.2026.100229_bib28","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","article-title":"Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance","volume":"80","author":"Mukherjee","year":"2020","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.bneo.2026.100229_bib29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"issue":"3-4","key":"10.1016\/j.bneo.2026.100229_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.18632\/genesandcancer.192","article-title":"Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPAR\u03b3","volume":"10","author":"Al-Jameel","year":"2019","journal-title":"Genes Cancer"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib31","first-page":"1706","article-title":"Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues","volume":"7","author":"Das","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"50","key":"10.1016\/j.bneo.2026.100229_bib32","doi-asserted-by":"crossref","first-page":"82783","DOI":"10.18632\/oncotarget.12635","article-title":"The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance","volume":"7","author":"Al Fayi","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55418-x","article-title":"FABP5 coordinates lipid signaling that promotes prostate cancer metastasis","volume":"9","author":"Carbonetti","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.bneo.2026.100229_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292483","article-title":"Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells","volume":"18","author":"Hillowe","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bneo.2026.100229_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118136","article-title":"Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer","volume":"122","author":"Wang","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bneo.2026.100229_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.667525","article-title":"FABP5, a novel immune-related mRNA prognostic marker and a target of immunotherapy for multiple myeloma","volume":"8","author":"Jia","year":"2021","journal-title":"Front Med"},{"issue":"16","key":"10.1016\/j.bneo.2026.100229_bib37","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41388-018-0597-1","article-title":"Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome","volume":"38","author":"Laouirem","year":"2019","journal-title":"Oncogene"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2026.100229_bib38","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1182\/blood-2021-150208","article-title":"Bone marrow adipocyte shapes metabolism and immunity in tumor microenvironment to promote multiple myeloma","volume":"138","author":"Shu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bneo.2026.100229_bib39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/leu.2017.307","article-title":"A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target","volume":"32","author":"Yan","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.bneo.2026.100229_bib40","article-title":"Doxorubicin resistance in breast cancer is mediated via the activation of FABP5\/PPAR\u03b3 and CaMKII signaling pathway","volume":"14","author":"Chen","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/cancers16010060","article-title":"FABP5 inhibition against PTEN-mutant therapy resistant prostate cancer","volume":"16","author":"Swamynathan","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pros.23921","article-title":"Docetaxel\/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth","volume":"80","author":"Carbonetti","year":"2020","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.bneo.2026.100229_bib43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s42255-024-01019-6","article-title":"Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring","volume":"6","author":"Sun","year":"2024","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/leu.2016.349","article-title":"Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells","volume":"31","author":"Yan","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib45","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1186\/s12967-024-05779-3","article-title":"Dissecting L-glutamine metabolism in acute myeloid leukemia: single-cell insights and therapeutic implications","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-023-02944-8","article-title":"Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer","volume":"21","author":"Chang","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mc.22485","article-title":"Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins","volume":"56","author":"Guaita-Esteruelas","year":"2017","journal-title":"Mol Carcinog"},{"issue":"2","key":"10.1016\/j.bneo.2026.100229_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10549-009-0577-9","article-title":"Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients","volume":"119","author":"Hancke","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.bneo.2026.100229_bib49","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1158\/0008-5472.CAN-17-2465","article-title":"Expression of adipocyte\/macrophage fatty acid-binding protein in tumor-associated macrophages promotes breast cancer progression","volume":"78","author":"Hao","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.bneo.2026.100229_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81184","article-title":"Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling","volume":"12","author":"Farrell","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.bneo.2026.100229_bib51","article-title":"Multiscale analysis and functional validation of the cellular and genetic determinants of skeletal disease","author":"Chai","year":"2024","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.bneo.2026.100229_bib1","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","article-title":"Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging","volume":"187","author":"Bandyopadhyay","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bneo.2026.100229_bib2","article-title":"Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2026.100229_bib52","article-title":"Stratification of multiple myeloma patients in the Commpass Study by single cell transcriptomics of plasma cells associates with clinical outcome","volume":"142","author":"Tafazzol","year":"2023","journal-title":"Blood"},{"issue":"52","key":"10.1016\/j.bneo.2026.100229_bib53","doi-asserted-by":"crossref","first-page":"86075","DOI":"10.18632\/oncotarget.13342","article-title":"Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.bneo.2026.100229_bib54","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1182\/blood-2011-01-330407","article-title":"Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease","volume":"118","author":"Fowler","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bneo.2026.100229_bib55","article-title":"Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression","volume":"102","author":"J","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.bneo.2026.100229_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/srep23115","article-title":"Identification of early myeloid progenitors as immunosuppressive cells","volume":"6","author":"Pu","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.bneo.2026.100229_bib58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41375-021-01443-7","article-title":"A comprehensive review of the impact of obesity on plasma cell disorders","volume":"36","author":"Parikh","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.bneo.2026.100229_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fendo.2020.00294","article-title":"Obesity-induced changes in bone marrow homeostasis","volume":"11","author":"Benova","year":"2020","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.bneo.2026.100229_bib60","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/0008-5472.CAN-20-1088","article-title":"Myeloma-modified adipocytes exhibit metabolic dysfunction and a senescence-associated secretory phenotype","volume":"81","author":"Fairfield","year":"2021","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bneo.2026.100229_bib61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/cancers13030364","article-title":"Bone marrow adipocytes: a link between obesity and bone cancer","volume":"13","author":"Reagan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bneo.2026.100229_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives","volume":"92","author":"Avgerinos","year":"2019","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib63","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.molmet.2014.06.005","article-title":"Diet-induced obesity promotes myelopoiesis in hematopoietic stem cells","volume":"3","author":"Singer","year":"2014","journal-title":"Mol Metab"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib64","first-page":"407","article-title":"Fatty acid-binding proteins: functional understanding and diagnostic implications","volume":"22","author":"Xu","year":"2019","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.bneo.2026.100229_bib65","article-title":"CD73(+)CD8(+) T cells define a subset with anti-tumor potential in DLBCL patients","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.bneo.2026.100229_bib66","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib67","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41467-024-47359-5","article-title":"Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk","volume":"15","author":"Piening","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.bneo.2026.100229_bib68","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stem.2023.04.005","article-title":"Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal","volume":"30","author":"Hao","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/biomedicines14010243","article-title":"In vivo models of diabetes: unravelling molecular pathways in metabolic and skeletal complications","volume":"14","author":"Ahmad Hairi","year":"2026","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.bneo.2026.100229_bib70","first-page":"1395","article-title":"Myeloma cell growth suppression by osteoblast-derived extracellular vesicles: the creation of a non-permissive niche for myeloma cells by bone-forming osteoblasts","volume":"110","author":"Kim","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.bneo.2026.100229_bib71","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control re-activation of dormant myeloma cells by remodeling the endosteal niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bneo.2026.100229_bib72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.bneo.2026.100229_bib73","first-page":"192","article-title":"Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model","volume":"91","author":"Yaccoby","year":"2006","journal-title":"Haematologica"},{"issue":"15","key":"10.1016\/j.bneo.2026.100229_bib74","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1182\/blood.2025028896","article-title":"Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics","volume":"146","author":"Yip","year":"2025","journal-title":"Blood"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:26:42Z","timestamp":1779294402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328026000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2950328026000403"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100229","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microenvironmentally derived fatty acid\u2013binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100229"}}